Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection

Keyphrases

• Neuroprotection 100%
• Mitochondrial Proteins 100%
• Paroxetine 100%
• Gp120 66%
• Selective Serotonin Reuptake Inhibitors 66%
• Neurotoxicity 33%
• Neuroprotective 33%
• HIV Infection 16%
• HIV Patients 16%
• Oxidative Stress 16%
• Viral Glycoprotein 16%
• FDA-approved Drugs 16%
• Specific Treatment 16%
• Serotonin Transporter 16%
• Systemic Administration 16%
• HIV-1 Tat 16%
• Cognitive Decline 16%
• Neuronal Cell Death 16%
• Neurodegeneration 16%
• Neurological Complications 16%
• Neuroprotective Drugs 16%
• Neural Stem Cells 16%
• HIV-associated Neurocognitive Disorders 16%
• Infected Macrophages 16%
• Induced Proliferation 16%
• Cognitive Dementia 16%
• Neuroregenerative 16%
• Calcium-dependent 16%
• Protective Efficacy 16%
• Mitochondrial Toxin 16%
• Peripheral Sensory Neuropathy 16%
• Neuroprotective Action 16%
• Neuroprotective Properties 16%
• Transgenic Animals 16%
• Neuroprotectant 16%
• Serotonin Reuptake 16%
• Liver Mitochondria 16%
• Protectins 16%
• Mitochondrial Potential 16%

Neuroscience

• Neuroprotection 100%
• Mitochondrial Protein 100%
• Paroxetine 100%
• Neuroprotective Agent 83%
• Selective Serotonin Reuptake Inhibitor 66%
• Human Immunodeficiency Virus 50%
• In Vivo 33%
• In Vitro 33%
• Neurotoxicity 33%
• Serotonin 16%
• Peripheral Neuropathy 16%
• Mitochondrion 16%
• Serotonin Transporter 16%
• Macrophage 16%
• Oxidative Stress 16%
• Neuronal Cell Death 16%
• Neurodegeneration 16%
• HIV Associated Dementia 16%
• Reuptake 16%
• Neural Stem Cell 16%
• Human Immunodeficiency Virus Protein 16%